- None
- Date
- Title
Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform
DURHAM, N.C. – (November 9, 2022) – Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The test ... Read More
Press ReleaseRapid, Near-Patient Monitoring of Heparin in Children
Multifunctional Platform for Viscoelastic aPTT and Fluorometric aFXa Whole Blood Testing in Near-Patient Settings for Pediatric Patients on Heparin Therapy Heparin monitoring tests for anti-Factor Xa activity (aFXa) and activated ... Read More
Blog,PosterNear-Patient Digital Microfluidics G6PD Assay
Preliminary Investigation into the Prevalence of G6PD Deficiency in a Pediatric African American Population using a Near-Patient Diagnostic Platform In this study, a near-patient digital microfluidics (DMF) glucose-6-phosphate dehydrogenase (G6PD) ... Read More
Blog,PosterNewborn Screening in Naples, Italy
There are multiple reasons to get excited about a trip to Italy. For our Staff Engineer, Hari Patel, his anticipation of picturesque scenery and amazing culinary experiences was second only to ... Read More
BlogAsk the Experts: Q&A Session with G6PD Experts, Dr. Mette Donneborg and Dr. Finn Ebbesen
In our Ask the Experts series, we share insights and key takeaways from experts in the Baebies network who are conducting research that contributes to a healthy start for everyone. ... Read More
Blog,finder,g6pd,g6pd deficiency